HealthTech180
  • Home
  • Activities
  • Our Team
  • Contact Us
Select Page

INTERCURE – CANNDOC signs strategic distribution agreement with S.L.E. of TEVA Pharmaceuticals

by admin | Sep 7, 2019 | Licensing

InterCure announced that subsidiary Canndoc has entered into a strategic distribution agreement with Salomon, Levin, Elstein (S.L.E.,) which is owned by Teva Pharmaceuticals Industries. Under terms of the agreement, S.L.E. will distribute Canndoc’s GMP products...
Follow Us
We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.

Categories

Follow Us

Tags

AI Alzheimer antibodies Biosimilar Cancer cardiovascular cell therapy CE Mark clinical trial Diagnostics Digital Health Drug Discovery EpiVax' FDA FDA approval funding fundraising HIV Immunogenicity Immunotherapies INVO Bioscience Licensing M&A medical device microbiome Neuro next-gen sequencing NGS PathAI pathology Pepticom peptides pharma PierianDx RNA robots Shape Therapeutics skin software SurgiMab Therapeutics therapies USA VIrology Virus

Home
Activities
Our Team
Contact Us

         contact@healthtech180.com

Privacy Policy

© 2022 HealthTech180 Advisory S.L.